CompanyDrug

CDE Prioritizes Review for Sanofi’s Nexviazyme and WinHealth’s Ravicti

CompanyDrug

Henlius Biotech’s HanBeiTai sBLA Accepted for HCC Treatment Review

CompanyDrug

Alphamab Oncology Doses First Patient in KN046-209 Study for NSCLC

CompanyDrug

Roche’s Rozlytrek Wins NMPA Approval for ROS1+ NSCLC Treatment

Company

EQRx Accelerates US Development of Two Chinese-Licensed Cancer Drugs

Company

Novartis Aims for China to Be Second – Largest Market by 2024

CompanyDeals

ESR Group Enters Life Sciences with Zhangjiang NEO Acquisition

CompanyDeals

ClouDr Partners with Ipsen to Expand Diphereline’s Reach in China

CompanyDeals

E-Health Now Raises Funds for Oncology and Cardiovascular Digital Health Products

CompanyDeals

KingYee and XINSEC IOT Form Strategic Partnership for Smart Ward Solutions

CompanyDrug

Chongqing Pharscin’s Gabexate Mesylate Passes GQCE as First Generic in China

CompanyDeals

Bennu Biotherapeutics Raises Over RMB100m in Angel+ Round for Global Pipeline Development